WATCHMAN is a one-time implant that is proven to reduce all-cause stroke risk among non-valvular AF patients comparably to long-term warfarin.
The WATCHMAN Implant procedure usually lasts about an hour and the patient is typically in the hospital for 24 hours.
In clinical trial, 92% of patients stopped taking warfarin once and for all 45 days after the procedure.1
WATCHMAN is the only FDA-approved LAAC device that safely and effectively reduces stroke risk in patients long-term. With a 95% implant success rate, WATCHMAN is the most studied LAAC device in the world and is the only device with long-term efficacy and safety data from both randomized clinical trials and multi-center registries.
1 Holmes, DR et al. JACC 2014; 64(1):1-12.
If you have a patient who may be a candidate for receiving the WATCHMAN Device, use this tool to find a trained implanter in your area.
Hear AF patients discuss how the WATCHMAN Device has changed their lives.
Dr. Vivek Reddy describes how the WATCHMAN Device impacts his AF patients.